Becker Capital Management’s Boston Scientific BSX Stock Holding History

Becker Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,658	Closed	-$230K	–	305
2026 Q1	$230K	Buy	3,658 +134	+4%	+$10.7K	0.01%	284
2025 Q4	$336K	Buy	3,524 +12	+0.3%	+$1.18K	0.01%	257
2025 Q3	$343K	Buy	3,512 +591	+20%	+$61.2K	0.01%	249
2025 Q2	$314K	Hold	2,921	–	–	0.01%	243
2025 Q1	$295K	Buy	2,921 +237	+9%	+$23.9K	0.01%	241
2024 Q4	$240K	Hold	2,684	–	–	0.01%	252
2024 Q3	$225K	Buy	+2,684	New	+$212K	0.01%	262
2015 Q1	–	Sell	-80,327	Closed	-$1.06M	–	142
2014 Q4	$1.06M	Sell	80,327 -14,376	-15%	-$184K	0.04%	88
2014 Q3	$1.12M	Sell	94,703 -3,117	-3%	-$39.3K	0.05%	89
2014 Q2	$1.25M	Sell	97,820 -18,723	-16%	-$243K	0.05%	89
2014 Q1	$1.58M	Sell	116,543 -253,613	-69%	-$3.33M	0.06%	91
2013 Q4	$4.45M	Sell	370,156 -45,566	-11%	-$538K	0.18%	85
2013 Q3	$4.88M	Sell	415,722 -1,061,973	-72%	-$11.5M	0.22%	83
2013 Q2	$13.7M	Buy	+1,477,695	New	+$12.5M	0.69%	63

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Becker Capital Management's BSX Position: Q2 2026 in Review

Becker Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,658 shares — an estimated $230K sold.

Becker Capital Management first reported a position in BSX in Q2 2013 and held it in 14 quarters. The position peaked at $13.7M in Q2 2013. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Becker Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Becker Capital Management sold 3,658 Boston Scientific shares in Q2 2026, an estimated $230K.
Becker Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 14 quarters.
Becker Capital Management's Boston Scientific position peaked at $13.7M in Q2 2013.
1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Becker Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.